Search research articles
Contact Us
Filters
Showing results (111-120 of 219) with videos related to
Page
of 22
Sort By:
Clinical Rheumatology
|
August 13, 2018
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
Claudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Mediators of Inflammation
|
August 19, 2014
Untangling the web of systemic autoinflammatory diseases
Donato Rigante, Giuseppe Lopalco, Antonio Vitale, et al.
Clinical Rheumatology
|
May 17, 2018
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies
Claudia Fabiani, Jurgen Sota, Donato Rigante, et al.
Vaccines
|
April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer
Emanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Clinical Rheumatology
|
March 25, 2014
Serum amyloid-A in Behçet's disease
Antonio Vitale, Donato Rigante, Giuseppe Lopalco, et al.
Clinical and Experimental Rheumatology
|
April 4, 2019
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis
Gian Marco Tosi, Jurgen Sota, Antonio Vitale, et al.
International Journal of Molecular Sciences
|
April 20, 2019
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
Alessandra Bettiol, Giuseppe Lopalco, Giacomo Emmi, et al.
Frontiers in Oncology
|
July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case report
Ettore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Journal of Clinical Medicine
|
January 21, 2023
From Bench to Bedside in Rheumatoid Arthritis from the "2022 GISEA International Symposium"
Antonio Vitale, Stefano Alivernini, Roberto Caporali, et al.
Frontiers in Oncology
|
January 10, 2022
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
Miriam Grazia Ferrara, Alessio Stefani, Sara Pilotto, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 219) with videos related to
Sort By:
Page
of 22
Clinical Rheumatology
|
August 13, 2018
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
Claudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Mediators of Inflammation
|
August 19, 2014
Untangling the web of systemic autoinflammatory diseases
Donato Rigante, Giuseppe Lopalco, Antonio Vitale, et al.
Clinical Rheumatology
|
May 17, 2018
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies
Claudia Fabiani, Jurgen Sota, Donato Rigante, et al.
Vaccines
|
April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer
Emanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Clinical Rheumatology
|
March 25, 2014
Serum amyloid-A in Behçet's disease
Antonio Vitale, Donato Rigante, Giuseppe Lopalco, et al.
Clinical and Experimental Rheumatology
|
April 4, 2019
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis
Gian Marco Tosi, Jurgen Sota, Antonio Vitale, et al.
International Journal of Molecular Sciences
|
April 20, 2019
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
Alessandra Bettiol, Giuseppe Lopalco, Giacomo Emmi, et al.
Frontiers in Oncology
|
July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case report
Ettore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Journal of Clinical Medicine
|
January 21, 2023
From Bench to Bedside in Rheumatoid Arthritis from the "2022 GISEA International Symposium"
Antonio Vitale, Stefano Alivernini, Roberto Caporali, et al.
Frontiers in Oncology
|
January 10, 2022
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
Miriam Grazia Ferrara, Alessio Stefani, Sara Pilotto, et al.
Page
of 22